Insight Folios Inc Trims Position in Colgate-Palmolive (NYSE:CL)

Insight Folios Inc cut its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 5.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,471 shares of the company’s stock after selling 217 shares during the quarter. Insight Folios Inc’s holdings in Colgate-Palmolive were worth $313,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Truist Financial Corp raised its stake in shares of Colgate-Palmolive by 13.2% in the third quarter. Truist Financial Corp now owns 322,496 shares of the company’s stock worth $22,933,000 after buying an additional 37,564 shares during the period. Advisors Asset Management Inc. grew its holdings in Colgate-Palmolive by 29.1% during the 3rd quarter. Advisors Asset Management Inc. now owns 7,027 shares of the company’s stock valued at $500,000 after purchasing an additional 1,586 shares during the last quarter. AXQ Capital LP bought a new stake in shares of Colgate-Palmolive during the 3rd quarter worth approximately $420,000. Ameriprise Financial Inc. increased its stake in Colgate-Palmolive by 25.8% in the 3rd quarter. Ameriprise Financial Inc. now owns 1,878,062 shares of the company’s stock worth $131,558,000 after buying an additional 385,249 shares during the period. Finally, KPP Advisory Services LLC bought a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $654,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Trading Down 0.2 %

NYSE CL traded down $0.23 during mid-day trading on Thursday, hitting $95.89. The company’s stock had a trading volume of 2,114,672 shares, compared to its average volume of 4,069,581. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.70. Colgate-Palmolive has a 52-week low of $67.62 and a 52-week high of $99.08. The stock’s fifty day simple moving average is $94.31 and its two-hundred day simple moving average is $87.95. The firm has a market capitalization of $78.67 billion, a P/E ratio of 30.35, a price-to-earnings-growth ratio of 3.54 and a beta of 0.39.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. The business had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The business’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.73 earnings per share. Research analysts expect that Colgate-Palmolive will post 3.53 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a $0.50 dividend. The ex-dividend date is Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.09%. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Royal Bank of Canada boosted their price target on Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a report on Monday, April 29th. Bank of America upped their price objective on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, April 29th. Morgan Stanley lifted their price objective on shares of Colgate-Palmolive from $101.00 to $103.00 and gave the company an “overweight” rating in a report on Tuesday, May 28th. Barclays boosted their price target on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 30th. Finally, Evercore ISI upped their target price on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a report on Monday, April 8th. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $93.83.

Check Out Our Latest Stock Analysis on CL

Insider Activity at Colgate-Palmolive

In related news, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the sale, the insider now owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the transaction, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the sale, the insider now owns 3,181 shares in the company, valued at approximately $297,328.07. The disclosure for this sale can be found here. Corporate insiders own 0.37% of the company’s stock.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.